Results
76,350 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Graeler DarrenChief Accounting Officer |  LDIloanDepot, Inc.Disposition to issuer | D | — 23.6K sh | Aug 7, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Graeler DarrenChief Accounting Officer | LDIloanDepot, Inc. Disposition to issuer | D | — 23.6K sh | Aug 7, 2026 |
| 9 | Ledbetter Samuel CraigSVP Chief Supply Chain Officer |  TSCOTRACTOR SUPPLY CO /DE/Grant or award | A | — 9,214 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 9 | Sharma ManiSVP, Group Controller |  AZNASTRAZENECA PLCGrant or award | A | $327 2 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 9 | Gallagher CindyCAO |  TDAYUSA TODAY Co., Inc.Tax withholding | F | $22K 2,731 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 9 | Zitting Shaun EllenChief Human Resources Officer |  NIQNIQ Global Intelligence plcTax withholding | F | $18K 1,516 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 9 | Gosser TrishaCFO | TDAYUSA TODAY Co., Inc. Tax withholding | F | $27K 3,326 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 9 | Gallagher CindyCAO | TDAYUSA TODAY Co., Inc. Option exercise | M | — 9,070 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 8 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER |  ACADACADIA PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $273K 9,292 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 8 | Pearce SamanthaEVP, Chief Commercial Officer |  JAZZJazz Pharmaceuticals plcTax withholding | F | $204K 780 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 8 | Harrison GinaVP and Corporate Controller |  QRVOQorvo, Inc.Tax withholding | F | $51K 534 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 8 | Mintz William B.SVP, Chief Strategy Officer |  CTEVClaritev CorpTax withholding | F | $95K 3,622 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 8 | Tabak ShawnCHIEF FINANCIAL OFFICER |  PRCHPorch Group, Inc.Open-market sale · 10b5-1 plan | SELL | $405K 25.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 8 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $170K 5,849 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 7 | Mayes Patrick AEVP & Chief Scientific Officer |  INCYINCYTE CORPOpen-market sale · 10b5-1 plan | SELL | $274K 2,207 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 7 | Geisser Melinda L.Chief People Services Officer |  SVVSavers Value Village, Inc.Option exercise · 10b5-1 plan | M | $21K 15.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 7 | Buckley Sean PatrickSee Remarks |  MGNIMAGNITE, INC.Option exercise · 10b5-1 plan | M | — 28.7K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 7 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $33K 23.3K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 7 | Werner Ryan D.SVP, CAO |  RIOTRiot Platforms, Inc.Open-market sale · 10b5-1 plan | SELL | $779K 35.4K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 6 | Reskos NikolaosChief Operating Officer |  SBLKStar Bulk Carriers Corp.Open-market sale · 10b5-1 plan | SELL | $148K 5,000 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 6 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $255K 14.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 6 | Flammer Martina M.D.Chief Medical Officer |  INSMINSMED IncOption exercise · 10b5-1 plan | M | $346K 18.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 6 | Baruch NiranChief Financial Officer |  AUDCAUDIOCODES LTDOpen-market sale · 10b5-1 plan | SELL | $18K 1,875 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 6 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $53K 16.7K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 6 | Baruch NiranChief Financial Officer | AUDCAUDIOCODES LTD Open-market sale · 10b5-1 plan | SELL | $19K 1,875 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 6 | Aldema LiorEVP and Chief Business Officer | AUDCAUDIOCODES LTD Open-market sale · 10b5-1 plan | SELL | $28K 2,812 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 6 | Aldema LiorEVP and Chief Business Officer | AUDCAUDIOCODES LTD Open-market sale · 10b5-1 plan | SELL | $28K 2,812 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 6 | Brown Christopher D.Director |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $170K 20.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 5 | Vivas EduardoDirector |  APPAppLovin CorpGift | G | — 213.7K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 5 | DerGurahian Jeffrey MichaelChief Investment Officer | LDIloanDepot, Inc. Grant or award | A | — 157.2K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 5 | Hite ChristopherEVP & Chairman, Partnering |  RPRXRoyalty Pharma plcGrant or award | A | — 11.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 5 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $145K 5,000 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 5 | Vivas EduardoDirector | APPAppLovin Corp Gift | G | — 213.7K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 5 | DerGurahian Jeffrey MichaelChief Investment Officer | LDIloanDepot, Inc. Disposition to issuer | D | — 157.2K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 5 | Flees Lori AnnDirector, President & CEO |  VVVVALVOLINE INCGrant or award | A | $962 27 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 5 | Buckley Sean PatrickSee Remarks | MGNIMAGNITE, INC. Option exercise · 10b5-1 plan | M | $399K 28.7K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 5 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Gift | G | — 18.5K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 5 | DerGurahian Jeffrey MichaelChief Investment Officer | LDIloanDepot, Inc. Grant or award | A | — 750.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 5 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Gift | G | — 3,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 4 | Werner Ryan D.SVP, CAO | RIOTRiot Platforms, Inc. Open-market sale · 10b5-1 plan | SELL | $59K 2,501 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 4 | Xu ZhenyuChief Scientific Officer |  SOPHSOPHiA GENETICS SAOption exercise · 10b5-1 plan | M | $9,840 3,000 sh | Aug 7, 2026 traded Aug 5, 2026 |